S87 Delivered Dose Intensity of Gemcitabine 1250 Mg/M2 With Cisplatin at 80 Mg/M2 (GC80) and 50 Mg/M2 (GC50) and Carboplatin AUC 6 (GCb6) in a Phase III Trial of Advanced Non-Small Cell Lung Cancer (NSCLC): Correlations With Clinical Outcomes

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2011-201054b.87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Multiple Myeloma: Comparison of Two Dose-Intensive Melphalan Regimens (100 vs 200 Mg/M2)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Fixed Dose Rate Versus Standard Dose Rate Infusion of Gemcitabine and Cisplatin in Advanced Stage Non-Small Cell Lung Cancer

Journal of Cancer Therapy
2015English

Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Survival Benefit of Intravenous Busulfan (120 Mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies

Journal of Stem Cell Research & Therapy
2016English

A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-Pm) and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

A Phase I Trial of a Combination of Cisplatin and Carboplatin in Advanced Non-Small Cell Lung Cancer. An Intensification of Platinum Dose by a Combination of Two Platinum Cmpounds.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1992English

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy